RecallRadar

FDA Device recall Z-2126-2013

Microscan plus Negative Breakpoint Combo 4 Sold outside of US only

On 2013-09-18 the FDA classified a Class I recall of Microscan plus Negative Breakpoint Combo 4 Sold outside of US only by Siemens Healthcare Diagnostics, citing confirmed increase in false susceptible and false intermediate misreads for Imipenem and/or meropenum on Synergies plus Negative and rap ID/S plus Negative panels read on Walk Awa….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-2126-2013
ClassificationClass I
Statusterminated
Initiated2013-08-21
Published2013-09-18
Last updated2026-09-13 11:53 UTC
CompanySiemens Healthcare Diagnostics
DistributionUS

Product

Microscan plus Negative Breakpoint Combo 4 Sold outside of US only. Product Usage: MicroScan¿ Synergies plus¿ Panels & MicroScan¿ Rapids plus (Negative) - For use in determining quantitative and/or qualitative antimicrobial agent susceptibility and/or identification for gram-negative bacteria.

Reason

Confirmed increase in false susceptible and false intermediate misreads for Imipenem and/or meropenum on Synergies plus Negative and rap ID/S plus Negative panels read on Walk Away System.

Identifiers

code_infoInternal Number - B1016-203; Catalog Number - 10460272

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2126-2013%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.